• Explore /
  • Poster
  • / Correlation of high serum interleukin-6 with clinical outcome and T cell response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Correlation of high serum interleukin-6 with clinical outcome and T cell response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Abstract Poster

Authors

Hong Jae Chon

Hongjae Chon

CHA Bundang Medical Center, Seongnam-Si, South Korea;

Hongjae Chon , Chan Kim , Hannah Yang , Jaekyung Cheon , Yeonjung Ha , Sung Hwan Lee , Beodeul Kang , Ilhwan Kim , Hyeyeong Kim , Won Suk Lee , Sanghoon Jung , Vince Gaillard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 596)

DOI

10.1200/JCO.2023.41.4_suppl.596

Abstract #

596

Poster Bd #

F8

Abstract Disclosures

Similar Posters

First Author: Aiwu Ruth He

First Author: Richard S. Finn

First Author: Daneng Li

First Author: Kevin Kim